Tessellate BIO
-
Drug News
Tessellate BIO Emerges from Stealth with €8 Million in Seed Funding, Pioneering Novel Synthetic Lethality Approaches in Oncology
Tessellate BIO, a preclinical stage biotechnology company specializing in innovative Synthetic Lethality approaches, made its official debut from stealth today…
Read More »